文献速递耳科与耳神经头颈外科

进展性前庭神经鞘瘤患者的听力损失病程

The Course of Hearing Loss in Patients With a Progressive Vestibular Schwannoma.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-02-05

回顾性队列研究纳入单侧前庭神经鞘瘤且具有≥2mm囊外生长、≥2次听力图的治疗前患者,评估听力损失自然病程。中位随访21个月后,58%(187/322)出现进展性听力损失(≥10 dB),中位年增6.4 dB;肿瘤进展(最大囊外直径)与感音神经性听力损失进展显著相关(F(2,228)=10.4,p<.001,R2=8%)。

要点

  • 初诊时86%患侧存在感音神经性听力损失(纯音平均≥20 dB),中位39 dB。
  • 中位随访21个月,58%(187/322)出现进展性听力损失(≥10 dB),中位年增6.4 dB。
  • 末次随访中位纯音平均56 dB,言语识别率中位由90%降至65%。

核心结论

  • 多数(58%)影像学证实为进展性前庭神经鞘瘤的患者在观察期间出现进展性感音神经性听力损失。
  • 肿瘤进展率、囊外肿瘤延伸和更长随访是与更多感音神经性听力损失相关的因素。

研究设计与样本

  • 回顾性队列研究,三级转诊中心。
  • 纳入标准为未接受治疗的单侧前庭神经鞘瘤,囊外生长≥2 mm且至少有2次听力图。
  • 采用多个听力结局参数综合评估,包括纯音平均(0.5、1、2、3 kHz的平均)及其年下降值。
  • 评估听力损失的预测因素:患者年龄、肿瘤大小/进展、随访时长、基线听力。

主要发现

  • 初诊时86%的患者患侧存在感音神经性听力损失(纯音平均≥20 dB),中位39 dB(四分位距27-51 dB)。
  • 中位随访时长21个月(四分位距13-34个月),之后58%(187/322)的患者出现进展性听力损失(≥10 dB),中位年增6.4 dB/年。
  • 末次随访时中位纯音平均为56 dB(四分位距37-73 dB)。
  • 中位言语识别率从90%(四分位距70%-100%)下降至65%(四分位距35%-100%)。
  • 校正随访后,肿瘤进展(最大囊外直径)与感音神经性听力损失进展显著相关(F(2,228)=10.4,p<.001,R2=8%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study evaluates the natural course of hearing loss (HL) prior to treatment in patients with progressive tumors and an indication for active intervention. Evaluating this patient group specifically can put hearing outcomes after vestibular schwannoma therapy into an adequate context. STUDY DESIGN: Retrospective cohort study. SETTING: Tertiary referral center. METHODS: Inclusion criteria comprised unilateral vestibular schwannomas prior to active treatment, with ≥2 mm extracanalicular (EC) tumor growth and ≥2 audiograms. We performed a comprehensive assessment of hearing using multiple outcome parameters including (the annual decrease in) pure-tone averages (PTAs; an average of 0.5, 1, 2, and 3 kHz). Predictors for HL were evaluated (patient age, tumor size/progression, follow-up duration, baseline hearing). RESULTS: At presentation, 86% of patients suffered from sensorineural HL on the affected side (≥20 dB PTA) with a median of 39 dB (interquartile rate [IQR]: 27-51 dB). The median follow-up duration was 21 months (IQR: 13-34 months), after which 58% (187/322) of patients experienced progressive HL (≥10 dB), with a median increase of 6.4 dB/year. At the last follow-up, the median PTA was 56 dB (IQR: 37-73). Median speech discrimination scores deteriorated from 90% (IQR: 70%-100%) to 65% (IQR: 35%-100%). Tumor progression (maximal EC diameter) was significantly correlated to the progression of sensorineural HL, corrected for follow-up (F(2,228) = 10.4, p < .001, R2 = 8%). CONCLUSION: The majority of patients (58%) with radiologically confirmed progressive vestibular schwannomas experience progressive sensorineural HL during observation. Tumor progression rate, EC tumor extension, and longer follow-up are factors associated with more sensorineural HL.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Koetsier KS, Locher H, Koot RW, et al. The Course of Hearing Loss in Patients With a Progressive Vestibular Schwannoma. Otolaryngol Head Neck Surg. 2023. PMID: 36939458. doi:10.1002/ohn.277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。